ReSuture
Private Company
Total funding raised: $18M
Overview
ReSuture is a US-based, private medical device company founded in 2019, specializing in advanced surgical simulation technology. Its core offering is a proprietary platform for creating realistic, data-generating vascular models used for training surgical residents and for medical device industry applications like product development and sales demonstrations. The company aims to modernize surgical education by providing ethical, efficient, and quantifiable alternatives to traditional training methods, supported by partnerships with academic and government institutions. ReSuture is in an early commercial stage, generating revenue through custom model development and its Open Vascular Training System.
Technology Platform
Proprietary platform for fabricating lifelike artificial human vasculature with customizable disease states, integrated with sensors for kinetic and movement data capture during surgical simulation.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
ReSuture competes in the surgical simulation market against established players like Surgical Science and 3D Systems, as well as a growing field of VR-based surgical trainers. Its differentiation lies in its focus on high-fidelity, procedure-specific vascular models with integrated data capture, offering a tangible, tactile alternative to purely virtual simulation.